MRNA - Marina Biotech, Inc.
| Previous Close | 1.12 |
| Open | 1.12 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 1.01 - 1.12 |
| 52 Week Range | 1.01 - 5.00 |
| Volume | 2,300 |
| Avg. Volume | 2,824 |
| Market Cap | 10.627M |
| Beta | 1.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.42 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•2 months ago
Marina Biotech Announces a New Publication on Prestalia®
City of Industry, CA, Feb. 27, 2018-- Marina Biotech, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and ...
- Marketwired•10 months ago
Marina Biotech Announces the Appointment of Dr. Vuong Trieu as Executive Chairman
Marina Biotech, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, announced ...
- Marketwired•10 months ago
Marina Biotech Appoints Chief Commercial Officer to Lead Sales and Marketing of Prestalia(R)
Marina Biotech, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and oncology, announced today that Erik ...
- Marketwired•10 months ago
Marina Biotech Acquires Prestalia(R), a U.S. FDA Approved Drug for Patients Whose Blood Pressure Is Not Adequately Controlled by Monotherapy
Marina Biotech, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, announced ...
- Accesswire•11 months ago
Marina Biotech to Participate in the 7th Annual LD Micro Invitational on June 7
LOS ANGELES, CA / ACCESSWIRE / May 31, 2017 / Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections ...
- Marketwired•11 months ago
Marina Biotech to Introduce Its Therapeutic Microbiome Programs Against Gastrointestinal Diseases
Marina Biotech, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, today announced ...
- Marketwired•last year
Marina Biotech to Participate in Joseph Gunnar's Pioneers 2017 Conference on May 2
Marina Biotech, Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, announced ...